Whitehawk Therapeutics, Inc.
WHWK
$3.92
$0.123.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | -- | 33.48% | 14.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -- | -- | 33.48% | 14.43% |
| Cost of Revenue | 25.66% | 32.81% | 251.88% | -32.97% | 10.53% |
| Gross Profit | -140.83% | -299.69% | -534.54% | 72.98% | -7.18% |
| SG&A Expenses | -46.92% | -27.62% | -24.73% | 20.67% | 6.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.97% | 8.67% | 151.57% | -10.06% | 8.94% |
| Operating Income | -31.34% | -81.40% | -251.32% | 22.01% | -6.97% |
| Income Before Tax | -27.24% | -41.45% | -260.80% | 499.23% | -12.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.24% | -41.45% | -260.80% | 499.23% | -12.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.24% | -41.45% | -260.80% | 499.23% | -12.32% |
| EBIT | -31.34% | -81.40% | -251.32% | 22.01% | -6.97% |
| EBITDA | -31.66% | -82.15% | -252.32% | 22.10% | -6.97% |
| EPS Basic | 50.21% | 44.74% | -41.06% | 371.71% | -11.82% |
| Normalized Basic EPS | 50.19% | 30.70% | -41.08% | 46.31% | -11.80% |
| EPS Diluted | 50.32% | 43.97% | -41.04% | 369.12% | -12.07% |
| Normalized Diluted EPS | 50.19% | 30.70% | -41.08% | 46.71% | -11.80% |
| Average Basic Shares Outstanding | 155.52% | 155.92% | 155.77% | 46.92% | 0.45% |
| Average Diluted Shares Outstanding | 155.52% | 155.92% | 155.77% | 48.00% | 0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |